Literature DB >> 20536245

Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.

Santanu Bhattacharya1, Padmaparna Chaudhuri, Akash K Jain, Ananya Paul.   

Abstract

The extremities of chromosomes end in a G-rich single-stranded overhang that has been implicated in the onset of the replicate senescence. The repeated sequence forming a G-overhang is able to adopt a four-stranded DNA structure called G-quadruplex, which is a poor substrate for the enzyme telomerase. Small molecule based ligands that selectively stabilize the telomeric G-quadruplex DNA, induce telomere shortening eventually leading to cell death. Herein, we have investigated the G-quadruplex DNA interaction with two isomeric bisbenzimidazole-based compounds that differ in terms of shape (V-shaped angular vs linear). While the linear isomer induced some stabilization of the intramolecular G-quadruplex structure generated in the presence of Na(+), the other, having V-shaped central planar core, caused a dramatic structural alteration of the latter, above a threshold concentration. This transition was evident from the pronounced changes observed in the circular dichroism spectra and from the gel mobility shift assay involving the G-quadruplex DNA. Notably, this angular isomer could also induce the G-quadruplex formation in the absence of any added cation. The ligand-quadruplex complexes were investigated by computational molecular modeling, providing further information on structure-activity relationships. Finally, TRAP (telomerase repeat amplification protocol) experiments demonstrated that the angular isomer is selective toward the inhibition of telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536245     DOI: 10.1021/bc9003298

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  8 in total

1.  A minimalistic approach to develop new anti-apicomplexa polyamines analogs.

Authors:  Esteban A Panozzo-Zénere; Exequiel O J Porta; Gustavo Arrizabalaga; Lucía Fargnoli; Shabana I Khan; Babu L Tekwani; Guillermo R Labadie
Journal:  Eur J Med Chem       Date:  2017-12-02       Impact factor: 6.514

Review 2.  Molecular dynamics simulations of G-DNA and perspectives on the simulation of nucleic acid structures.

Authors:  Jiří Sponer; Xiaohui Cang; Thomas E Cheatham
Journal:  Methods       Date:  2012-04-16       Impact factor: 3.608

3.  Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

Authors:  Ananya Paul; Akash K Jain; Santosh K Misra; Basudeb Maji; K Muniyappa; Santanu Bhattacharya
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

4.  Synthesis and discovery of 18α-GAMG as anticancer agent in vitro and in vivo via down expression of protein p65.

Authors:  Wen-jian Tang; Yong-an Yang; He Xu; Jing-bo Shi; Xin-hua Liu
Journal:  Sci Rep       Date:  2014-11-19       Impact factor: 4.379

5.  Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.

Authors:  Xing Chen; Gao-Feng Zha; Jie Quan Wang; Xin-Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin.

Authors:  Jie Quan Wang; Meng Di Yang; Xing Chen; Yang Wang; Liu Zeng Chen; Xiu Cheng; Xin Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

7.  Naphthalenediimide-Linked Bisbenzimidazole Derivatives as Telomeric G-Quadruplex-Stabilizing Ligands with Improved Anticancer Activity.

Authors:  Souvik Sur; Vinod Tiwari; Devapriya Sinha; Mohammad Zahid Kamran; Kshatresh Dutta Dubey; Gopinatha Suresh Kumar; Vibha Tandon
Journal:  ACS Omega       Date:  2017-03-16

8.  Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.

Authors:  Xu Han; Yun Long Yu; Duo Ma; Zhao Yan Zhang; Xin Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.